drugset / Trial / NCT02307383

Pilot Study of the Effectiveness of Probiotics and Lactitol for the Decolonization of OXA-48 (Carbapenemase) Producing Klebsiella Pneumoniae Among Rectal Carriers

NCT02307383

NaSingle-groupOpen-labelTreatment

Summary

The combination of Lactitol and Probiotics (Lactobacillus acidophilus and Lactobacillus Biphidus) administered orally is an effective strategy of intestinal decolonization of Enterobacter produced OXA-48-type carbapenemase. The purpose of this study is to determine the effectiveness of Lactitol and Probiotics for the intestinal decolonization of people who carried Klebsiella pneumoniae produced OXA-48-type Carbapenemase.

Timeline

Start
2014-10
Primary completion
2015-10
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Bifidobacterium bifidum Unknown 1e+09 cells Oral
Subject Lactitol Small molecule 10 g Oral
Subject Lactobacillus acidophilus Other / unclassified 1e+09 cells Oral

Indications

No indication recorded.